Review Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer Abhishek Manoj Ranaware 1,†, Kishore Banik 2,†, Vishwas Deshpande 1, Ganesan Padmavathi 2, Nand Kishor Roy 2, Gautam Sethi 3,4,5,*, Lu Fan 5, Alan Prem Kumar 6,7,8 and Ajaikumar B. Kunnumakkara 2,* 1 Department of Zoology, Yashwantrao Chavan Institute of Science, Satara, Maharashtra 415001, India;
[email protected] (A.M.R.);
[email protected] (V.D.) 2 Cancer Biology Laboratory and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India;
[email protected] (K.B.);
[email protected] (G.P.);
[email protected] (N.K.R.) 3 Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam 4 Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam 5 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore;
[email protected] 6 Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore;
[email protected] 7 Medical Science Cluster, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore 8 Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA 6009, Australia * Correspondence:
[email protected] or
[email protected] (G.S.);
[email protected] or
[email protected] (A.B.K.); Tel.: +65-65163-267 (G.S.); +91-361-258-2231 (A.B.K.) † These authors contributed equally to this work.